A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)
Condition: Osteoporosis Interventions: Drug: Zoledronic acid, once; Drug: Zoledronic acid, twice Sponsor: Yonsei University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clinical Trials | Orthopaedics | Osteoporosis | Reclast | Research | Study | Women | Zometa